targeted Therapies
With no Compromise

PDC Therapeutics is a clinical-stage biotechnology start-up developing smart nanomedicines for targeted therapies.

Superior Therapeutic Index

Sagitta© biodegradable conjugation platforms are discovered to reinforce ideal performances in terms of the therapeutic index, pharmacokinetics and manufacturability.

Read More
targeted Therapies With no Compromise

PDC Therapeutics is a clinical-stage biotechnology start-up developing smart nanomedicines for targeted therapies.

Superior Therapeutic Index

Sagitta© biodegradable conjugation platforms are discovered to reinforce ideal performances in terms of the therapeutic index, pharmacokinetics and manufacturability.

Read More

PDC Therapeutics to attend ESMO 2022 Congress for Poster Presentation

PDC Therapeutics, a biotech company developing targeted Polymer-Drug Conjugate technologies…

Publications

Building better docetaxel therapy with nanocarrier technology, covered by BioWorld

PDC Therapeutics SA has passed the first test of its novel nanocarrier technology…

News on the Media